(Q35032152)

5 August 2017

1 reference

title

Matrix metalloproteinase-9 in lung remodeling (English)

1 reference

5 August 2017

Jeffrey J Atkinson

1

1 reference

PubMed ID

12495928

5 August 2017

Robert M Senior

series ordinal

2

1 reference

5 August 2017

1 January 2003

1 reference

American Journal of Respiratory Cell and Molecular Biology

5 August 2017

1 reference

5 August 2017

28

1 reference

5 August 2017

1

1 reference

5 August 2017

12-24

1 reference

Matrix metalloproteinases

5 August 2017

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Matrix metalloproteinases in lung biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Structural properties of matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

How matrix metalloproteinases regulate cell behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

A genome-wide search for quantitative trait loci underlying asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12.2-13.1

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Functional Polymorphism in the Regulatory Region of Gelatinase B Gene in Relation to Severity of Coronary Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

The structural basis for the elastolytic activity of the 92-kDa and 72-kDa gelatinases. Role of the fibronectin type II-like repeats

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Activation of the endogenous metalloproteinase, gelatinase, by triggered human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

New functions for the matrix metalloproteinases in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Tumor progression: defining the soil round the tumor seed

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Matrix metalloproteinases in tumor invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Tissue levels of active matrix metalloproteinase-2 and -9 in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Circulating 92-kilodalton matrix metalloproteinase (MMP-9) activity is enhanced in the euglobulin plasma fraction of head and neck squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Marimastat as maintenance therapy for patients with advanced gastric cancer: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Matrix metalloproteinases and matrix metalloproteinase inhibitors in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Gelatinase B deficiency impairs reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Prevention of interleukin-8-induced mobilization of hematopoietic progenitor cells in rhesus monkeys by inhibitory antibodies against the metalloproteinase gelatinase B (MMP-9).

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Neutrophils are indispensable for hematopoietic stem cell mobilization induced by interleukin-8 in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Localization of gelatinolytic activity can be detected in breast cancer tissues by film in situ zymography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Gelatinase B is required for alveolar bronchiolization after intratracheal bleomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Immunohistochemical localisation of the matrix metalloproteinases MMP-3 and MMP-9 within the airways in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Characteristic elevation of matrix metalloproteinase activity in idiopathic interstitial pneumonias

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Expression of 92-kDa type IV collagenase mRNA by eosinophils associated with basal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

High expression of 92-kD type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Global analysis of gene expression in pulmonary fibrosis reveals distinct programs regulating lung inflammation and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Gelatinases A and B are up-regulated in rat lungs by subacute hyperoxia: pathogenetic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Human T lymphocytes synthesize the 92 kDa type IV collagenase (gelatinase B).

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Secretion of gelatinases and tissue inhibitors of metalloproteinases by human lung cancer cell lines and revertant cell lines: not an invariant correlation with metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Altered matrix metalloproteinase expression associated with oncogene-mediated cellular transformation and metastasis formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Airway epithelial cell migration dynamics. MMP-9 role in cell-extracellular matrix remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Migration of neutrophils across human pulmonary endothelial cells is not blocked by matrix metalloproteinase or serine protease inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Impaired swallowing reflex in patients with obstructive sleep apnea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Matrix metalloproteinase gelatinase B (MMP-9) coordinates and effects epithelial regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Matrix metalloproteinases. Matrix degradation and more

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

The serpin alpha1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Use of the tetracycline-controlled transcriptional silencer (tTS) to eliminate transgene leak in inducible overexpression transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Airway remodelling in the pathogenesis of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Goblet cell degranulation after antigen challenge in sensitized guinea pigs. Role of neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

A murine model of toluene diisocyanate-induced asthma can be treated with matrix metalloproteinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

The selective phosphodiesterase 4 inhibitor RP 73-401 reduced matrix metalloproteinase 9 activity and transforming growth factor-beta release during acute lung injury in mice: the role of the balance between Tumor necrosis factor-alpha and interleuk

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Matrix metalloproteinase-9 deficiency impairs cellular infiltration and bronchial hyperresponsiveness during allergen-induced airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Evidence of type II pneumocyte apoptosis in the pathogenesis of idiopathic pulmonary fibrosis (IFP)/usual interstitial pneumonia (UIP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Matrix metalloproteinases 2, 9, and 13, and tissue inhibitors of metalloproteinases 1 and 2 in experimental lung silicosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Repeated endotoxin exposure induces interstitial fibrosis associated with enhanced gelatinase (MMP-2 and MMP-9) activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Modulation of airway remodeling-associated mediators by the antifibrotic compound, pirfenidone, and the matrix metalloproteinase inhibitor, batimastat, during acute lung injury in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Chronic obstructive pulmonary disease - part 2: pathology and biochemistry of emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Amplification of inflammation in emphysema and its association with latent adenoviral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Altered cytokine regulation in the lungs of cigarette smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Airway inflammation in severe chronic obstructive pulmonary disease: relationship with lung function and radiologic emphysema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Remodeling in asthma and chronic obstructive lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Evolving concepts in the pathogenesis of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Interferon gamma induction of pulmonary emphysema in the adult murine lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Spontaneous air space enlargement in the lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Human Monocyte-Derived Dendritic Cells Produce Bioactive Gelatinase B: Inhibition by IFN-β

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2002-0166TR

21 January 2018

Identifiers

DOI

10.1165/RCMB.2002-0166TR

1 reference

5 August 2017

1 reference

PubMed ID

12495928